ALFA News
Straight from the exchange filing
Every announcement IOL Chemicals & Pharmaceuticals has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every IOL Chemicals & Pharmaceuticals announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
IOL Chemicals & Pharmaceuticals (IOLCP) receives EU-REACH registration for Triacetin, enabling exports to the EU. Company reports TTM revenue of ₹2,523.63 Cr.
IOL Chemicals and Pharmaceuticals (IOLCP) announces a ₹495 Cr expansion, adding 6,000 MTPA Ibuprofen capacity and entering the CDMO segment. Commercial by 2027.
